Question 1

Does ProShare Advisors own CRSP stock?

Accepted Answer

Yes. As of its Q3 2026 13F, ProShare Advisors holds 15,043 shares of CRSP (CRISPR Therapeutics), worth $832,180.

Question 2

How many shares of CRSP does ProShare Advisors own?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors holds 15,043 shares of CRSP (CRISPR Therapeutics).

Question 3

What is ProShare Advisors' CRSP position worth?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors' CRSP position is worth $832,180.

Question 4

Is ProShare Advisors buying or selling CRSP?

Accepted Answer

In Q3 2026, ProShare Advisors reduced its CRSP position by 732 shares (-4.6%).

Question 5

When did ProShare Advisors first buy CRSP?

Accepted Answer

ProShare Advisors already held CRSP in its Q4 2018 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	15,043	-4.6%	$832,180	0.0%	$55.32	0
2026-Q2	Decreased	15,775	-12.0%	$860,368	0.0%	$54.54	0
2026-Q1	Decreased	17,927	-12.3%	$852,788	0.0%	$47.57	0
2025-Q4	Increased	20,447	+14.5%	$1.1M	0.0%	$52.44	29
2025-Q3	Decreased	17,853	-13.9%	$1.2M	0.0%	$64.81	0
2025-Q2	New	20,732	—	$1M	0.0%	$48.64	35
2024-Q4	Exited	0	-100.0%	$0	0.0%	$39.36	0
2024-Q3	Decreased	5,358	-3.8%	$251,718	0.0%	$46.98	0